Malignant gliomas are the most common and lethal primary central nervous system tumors and are only modestly responsive to treatment with radiation and conventional chemotherapies. Better treatments may come from approaches which target biochemical pathways specifically utilized by glioma tumors for growth and survival. To help identify these glioma-relevant genes and pathways, the Genomics and Bioinformatics core will provide detailed microarray-based genomic profiling of human and mouse gliomas to support the Projects of the POL, will supply expertise in bioinformatics needed to analyze the data, and will integrate the rapidly growing body of glioma data generated from external sources, such as The Cancer Genome Atlas. The Core will directly provide high-resolution array-based comparative genomic hybridization as a service to the Projects, and will integrate other genomic data, such as profiling of gene expression, genome methylation, single nucleotide polymorphism and gene resequencing. The Core plays a critical role for the overall Program goals by linking the genomic events seen in human GBM tumors with the powerful functional assays, models and screens which are used within the Projects to dissect the biology of glioma. The Genomics and Bioinformatics Core has three specific aims: 1) To provide high-resolution genomic profiling of mouse and human gliomas. 2) To perform integration and computational analyses of the broad spectrum of GBM genomic data 3) To develop and implement emerging technologies relevant to glioma research The Core personnel bring expertise and established resources particularly suited to achieving these Aims and to the overarching scientific goals of the P01.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA095616-09
Application #
8234815
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2011-12-31
Budget Start
2011-03-01
Budget End
2012-02-29
Support Year
9
Fiscal Year
2011
Total Cost
$209,365
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Reardon, Colin; Murray, Kaitlin; Lomax, Alan E (2018) Neuroimmune Communication in Health and Disease. Physiol Rev 98:2287-2316
Roncali, Emilie; Stockhoff, Mariele; Cherry, Simon R (2017) An integrated model of scintillator-reflector properties for advanced simulations of optical transport. Phys Med Biol 62:4811-4830
Nanavaty, Vishal; Sandhu, Ranjodh; Jehi, Sanaa E et al. (2017) Trypanosoma brucei RAP1 maintains telomere and subtelomere integrity by suppressing TERRA and telomeric RNA:DNA hybrids. Nucleic Acids Res 45:5785-5796
Liu, Rui; Yang, Guang; Zhou, Meng-Hua et al. (2016) Flotillin-1 downregulates K(+) current by directly coupling with Kv2.1 subunit. Protein Cell 7:455-60
Schrager-Lavelle, Amanda; Herrera, Leslie A; Maloof, Julin N (2016) Tomato phyE Is Required for Shade Avoidance in the Absence of phyB1 and phyB2. Front Plant Sci 7:1275
Hu, Baoli; Wang, Qianghu; Wang, Y Alan et al. (2016) Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell 167:1281-1295.e18
Poornima, Gopalakrishna; Shah, Shanaya; Vignesh, Venkadasubramanian et al. (2016) Arginine methylation promotes translation repression activity of eIF4G-binding protein, Scd6. Nucleic Acids Res 44:9358-9368
Frost, Bess; Bardai, Farah H; Feany, Mel B (2016) Lamin Dysfunction Mediates Neurodegeneration in Tauopathies. Curr Biol 26:129-36
Leonard, Paul G; Satani, Nikunj; Maxwell, David et al. (2016) SF2312 is a natural phosphonate inhibitor of enolase. Nat Chem Biol 12:1053-1058
Hiu, Takeshi; Farzampour, Zoya; Paz, Jeanne T et al. (2016) Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic target. Brain 139:468-80

Showing the most recent 10 out of 146 publications